"In vivo" imaging of atherosclerosis

Augusto Gallino; Matthias Stuber; Filippo Crea; Erling Falk; Roberto Corti; John Lekakis; Jürg Schwitter; Paolo Camici; Oliver Gaemperli; Marcello Di Valentino; John Prior; Hector M. Garcia-Garcia; Charalambos Vlachopoulos; Francesco Cosentino; Stephan Windecker; Giovanni Pedrazzini; Richard Conti; François Mach; Raffaele De Caterina; Peter Libby

doi:10.1016/j.atherosclerosis.2012.04.007

"In vivo" imaging of atherosclerosis

Augusto Gallino
, Matthias Stuber
, Filippo Crea
, Erling Falk
, Roberto Corti
, John Lekakis
, Jürg Schwitter
, Paolo Camici
, Oliver Gaemperli
, Marcello Di Valentino
, John Prior
, Hector M. Garcia-Garcia
, Charalambos Vlachopoulos
, Francesco Cosentino
, Stephan Windecker
, Giovanni Pedrazzini
, Richard Conti
, François Mach
, Raffaele De Caterina
, Peter Libby

Cardiology Dep
Center for Biomedical Imaging (CIBM), University of Lausanne
Aarhus University
University of Zurich
National and Kapodistrian University of Athens
University of Lausanne
Vita-Salute San Raffaele University
Erasmus University Rotterdam
Hippokration General Hospital
Sant'Andrea Hospital
University of Bern
Cardiocentro Ticino CCT
Health Science Center
University of Geneva
University Cardiology Dep.
Harvard University

Risultato della ricerca: Contributo in rivista › Articolo

44 Citazioni (Scopus)

Abstract

Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that usually takes decades before overt disease eventually appears as a consequence of progressive obstruction or abrupt thrombotic occlusion. This silent course makes necessary to develop predictors of disease long before symptomatic lesions develop. Besides several classical risk factors and new emerging humoral risk predictors, imaging may constitute a formidable diagnostic and prognostic tool in order to identify presence, extension, progression (or regression) of disease as well as vulnerability of atherosclerotic lesions. This review summarizes the rapidly growing clinical and research field in imaging atherosclerosis from different perspectives opening important opportunities for timely detection and treatment of atherosclerosis.

Lingua originale	Inglese
pagine (da-a)	25-36
Numero di pagine	12
Rivista	Atherosclerosis
Volume	224
DOI	https://doi.org/10.1016/j.atherosclerosis.2012.04.007
Stato di pubblicazione	Pubblicato - 2012

Keywords

Atherosclerosis
Imaging

Accesso al documento

10.1016/j.atherosclerosis.2012.04.007

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Gallino, A., Stuber, M., Crea, F., Falk, E., Corti, R., Lekakis, J., Schwitter, J., Camici, P., Gaemperli, O., Di Valentino, M., Prior, J., Garcia-Garcia, H. M., Vlachopoulos, C., Cosentino, F., Windecker, S., Pedrazzini, G., Conti, R., Mach, F., De Caterina, R., & Libby, P. (2012). "In vivo" imaging of atherosclerosis. Atherosclerosis, 224, 25-36. https://doi.org/10.1016/j.atherosclerosis.2012.04.007

@article{01410e10a0b74228b4dbba20bfda9f20,

title = "{"}In vivo{"} imaging of atherosclerosis",

abstract = "Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that usually takes decades before overt disease eventually appears as a consequence of progressive obstruction or abrupt thrombotic occlusion. This silent course makes necessary to develop predictors of disease long before symptomatic lesions develop. Besides several classical risk factors and new emerging humoral risk predictors, imaging may constitute a formidable diagnostic and prognostic tool in order to identify presence, extension, progression (or regression) of disease as well as vulnerability of atherosclerotic lesions. This review summarizes the rapidly growing clinical and research field in imaging atherosclerosis from different perspectives opening important opportunities for timely detection and treatment of atherosclerosis.",

keywords = "Atherosclerosis, Imaging, Atherosclerosis, Imaging",

author = "Augusto Gallino and Matthias Stuber and Filippo Crea and Erling Falk and Roberto Corti and John Lekakis and J{\"u}rg Schwitter and Paolo Camici and Oliver Gaemperli and \{Di Valentino\}, Marcello and John Prior and Garcia-Garcia, \{Hector M.\} and Charalambos Vlachopoulos and Francesco Cosentino and Stephan Windecker and Giovanni Pedrazzini and Richard Conti and Fran{\c c}ois Mach and \{De Caterina\}, Raffaele and Peter Libby",

year = "2012",

doi = "10.1016/j.atherosclerosis.2012.04.007",

language = "English",

volume = "224",

pages = "25--36",

journal = "Atherosclerosis",

issn = "0021-9150",

}

Gallino, A, Stuber, M, Crea, F, Falk, E, Corti, R, Lekakis, J, Schwitter, J, Camici, P, Gaemperli, O, Di Valentino, M, Prior, J, Garcia-Garcia, HM, Vlachopoulos, C, Cosentino, F, Windecker, S, Pedrazzini, G, Conti, R, Mach, F, De Caterina, R & Libby, P 2012, '"In vivo" imaging of atherosclerosis', Atherosclerosis, vol. 224, pagg. 25-36. https://doi.org/10.1016/j.atherosclerosis.2012.04.007

TY - JOUR

T1 - "In vivo" imaging of atherosclerosis

AU - Gallino, Augusto

AU - Stuber, Matthias

AU - Crea, Filippo

AU - Falk, Erling

AU - Corti, Roberto

AU - Lekakis, John

AU - Schwitter, Jürg

AU - Camici, Paolo

AU - Gaemperli, Oliver

AU - Di Valentino, Marcello

AU - Prior, John

AU - Garcia-Garcia, Hector M.

AU - Vlachopoulos, Charalambos

AU - Cosentino, Francesco

AU - Windecker, Stephan

AU - Pedrazzini, Giovanni

AU - Conti, Richard

AU - Mach, François

AU - De Caterina, Raffaele

AU - Libby, Peter

PY - 2012

Y1 - 2012

N2 - Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that usually takes decades before overt disease eventually appears as a consequence of progressive obstruction or abrupt thrombotic occlusion. This silent course makes necessary to develop predictors of disease long before symptomatic lesions develop. Besides several classical risk factors and new emerging humoral risk predictors, imaging may constitute a formidable diagnostic and prognostic tool in order to identify presence, extension, progression (or regression) of disease as well as vulnerability of atherosclerotic lesions. This review summarizes the rapidly growing clinical and research field in imaging atherosclerosis from different perspectives opening important opportunities for timely detection and treatment of atherosclerosis.

AB - Atherosclerosis is a systemic and multifocal disease, which starts early in life, and that usually takes decades before overt disease eventually appears as a consequence of progressive obstruction or abrupt thrombotic occlusion. This silent course makes necessary to develop predictors of disease long before symptomatic lesions develop. Besides several classical risk factors and new emerging humoral risk predictors, imaging may constitute a formidable diagnostic and prognostic tool in order to identify presence, extension, progression (or regression) of disease as well as vulnerability of atherosclerotic lesions. This review summarizes the rapidly growing clinical and research field in imaging atherosclerosis from different perspectives opening important opportunities for timely detection and treatment of atherosclerosis.

KW - Atherosclerosis

KW - Imaging

KW - Atherosclerosis

KW - Imaging

UR - http://hdl.handle.net/10807/28278

U2 - 10.1016/j.atherosclerosis.2012.04.007

DO - 10.1016/j.atherosclerosis.2012.04.007

M3 - Article

SN - 0021-9150

VL - 224

SP - 25

EP - 36

JO - Atherosclerosis

JF - Atherosclerosis

ER -

"In vivo" imaging of atherosclerosis

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo